Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2022

Young Oncologist Boxing session

Pro: Tumor mutional burden as a tumor agnostic biomarker?

Date

10 Sep 2022

Session

Young Oncologist Boxing session

Topics

Clinical Research;  Cancer Biology;  Tumour Immunology;  Translational Research;  Cancer in Adolescents and Young Adults (AYA);  Targeted Therapy;  Molecular Oncology;  Immunotherapy;  Cancer Diagnostics

Tumour Site

Thyroid Cancer;  Small Cell Lung Cancer;  Carcinoma of Unknown Primary Site (CUP);  Non-Small Cell Lung Cancer;  Anal Cancer;  Cervical Cancer;  Vulvar and Vaginal Cancers;  Colon and Rectal Cancer

Presenters

Aurélien Marabelle

Authors

A. Marabelle

Author affiliations

  • Drug Development Department, Institut Gustave Roussy, 94805 - Villejuif/FR

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.